See also: Gammaglobulin (IVIg)
Intravenous Immune Globulin (IVIG) is a human blood product consisting of antibodies which is used to treat immune disorders including myaesthenia gravis and multifocial motor neuropathy. It is sometimes trialed on ALS patients during the diagnostic process to rule out other illnesses.
Read more...
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Other | 31 |
|
|
|
8 | ||
| Slow my MS progress | 29 |
|
|
|
|
8 | |
| Slow my ALS progress | 10 |
|
1 | ||||
| Fatigue | 6 |
|
|
2 | |||
| Peripheral Neuropathy | 4 | 0 | |||||
| Pain | 3 | 0 |
See all 56 patients currently taking IVIg Intravenous Immuno Globulin
Mouse over the table for more information
Top 10 dosages based on patients currently taking IVIg Intravenous Immuno Globulin. See all 42 dosages ►
| as needed | 0.5 g monthly | 1 g monthly | 1.5 g monthly | 5 g monthly | 6 g monthly | 10 g monthly | 12 g monthly | 15 mg monthly | 25 g monthly | 25 mg monthly | 30 g monthly | 30 mg monthly | 1 g daily | 15 g every other week | 40 g monthly | 40 mcg monthly | 20 mg every other week | 50 mg monthly | 55 g monthly | 60 g monthly | 60 mg monthly | 65 mg monthly | 35 g every other week | 90 g monthly | 100 g monthly | 60 g every other week | 140 mg monthly | 150 g monthly | 150 mg monthly | 156 g monthly | 180 mg monthly | 330 mcg monthly | 442 mg monthly | 500 mL monthly | 550 mg monthly | 800 mg monthly | 1000 g monthly | 2000 mg monthly | 3900 mL monthly | 400 mg daily | 10000 mg daily | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1
|
1
|
2
|
1
|
3
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
3
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
||
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Did not seem to work
|
28 | 42% |
|
|
Course of treatment ended
|
25 | 37% |
|
|
Doctor's advice
|
21 | 31% |
|
|
Other
|
8 | 12% |
|
|
Side effects too severe
|
6 | 9% |
|
|
Expense
|
4 | 6% |
|
See all 66 patients who’ve stopped taking IVIg Intravenous Immuno Globulin
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 21, 2009.